If the results are confirmed in humans, the implications for personalized therapies for other cancers could mean fewer radiation treatments, or perhaps, ideally, one single high-dose treatment.
A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumors can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumors in check with oxygen enhancement.
In research examining tissue oxygenation levels and predicting radiation response, UT Southwestern scientists led by Dr. Ralph Mason reported in the June 27 online issue of Magnetic Resonance in Medicine that countering hypoxic and aggressive tumors with an “oxygen challenge” – inhaling oxygen while monitoring tumor response – coincides with a greater delay in tumor growth in an irradiated animal model.
Over the past several years, the research of Dr. Mason, professor of radiology and the paper’s senior author, and his colleagues has been building on findings that show lack of oxygen actually stimulates the growth of new blood vessels in tumors and leads to metastasis and genetic instability in cancer. The theory follows that breathing oxygen or enriching the oxygen content of hypoxic (low in oxygen) cancer tissues improves therapy.
In the current study, supported by the National Cancer Institute, smaller tumors based on magnetic resonance imaging were found to be significantly better oxygenated than larger ones. This confirmed previous investigations that show a range of hypoxic environments depending on the size of the tumor.
“The next step is clinical trials to assess tumor response to radiation therapy,” said Dr. Mason, director of the cancer imaging program at the medical center. “Tumors determined to be hypoxic can be evaluated and made responsive through mild and easy-to-administer interventions, such as breathing more oxygen or taking a vasoactive drug. Monitoring the response to oxygen breathing tells us which tumors will benefit.”
If the results are confirmed in humans, the implications for personalized therapies for other cancers could mean fewer radiation treatments, or perhaps, ideally, one single high-dose treatment. Lung cancer, for instance, is a form of the disease whose tumors are poorly oxygenated despite being located in the principle organ charged with oxygenating the blood.
“The ability to stratify tumors based on hypoxia offers new opportunities to tailor therapy to tumor characteristics, potentially enhancing success through personalized medicine,” Dr. Mason said.
Together with Dr. Robert Timmerman, professor of radiation oncology at the Harold C. Simmons Cancer Center, and Dr. Ivan Pedrosa, professor of radiology and the Advanced Imaging Research Center, Dr. Mason is starting clinical trials to assess the effectiveness of oxygenation during treatment with stereotactic body radiation in humans – work that is supported by the Cancer Prevention and Research Institute of Texas (CPRIT) through one of its Multi-Investigator Research Awards.
With CPRIT support, Dr. Mason’s team has worked to understand how low oxygen concentration can cause radiation resistance in tumors. In some cases, the simple addition of oxygen to stereotactic body radiation greatly improves response. The key is to identify those patients who will benefit.
The Latest Bing News on:
Personalized cancer therapies
- Global Companion Diagnostics Research Report 2024-2029: Innovations in Companion Diagnostics Boost Drug Development and Personalized Medicineon May 9, 2024 at 12:43 am
Factors such as the increasing importance of companion diagnostics in drug development, rising cancer incidence, and the growing adoption of targeted therapies are driving market growth.
- AI-Powered Model Identifies Most Potent Cancer-Killing Immune Cellson May 8, 2024 at 8:46 am
In the journal Nature Biotechnology, scientists at Ludwig Cancer Research reported the development of an AI model to identify the most effective immune cells for cancer immunotherapy.
- AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapyon May 7, 2024 at 9:46 pm
Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer ...
- mRNA vaccine tackles deadly brain cancer in human trialon May 6, 2024 at 6:45 am
Glioblastoma is one of the most deadly cancers, with few treatment options available. Now, a small human clinical trial has demonstrated an mRNA vaccine that quickly rallies the immune system to fight ...
- Personalized mRNA vaccines: A new approach in melanoma treatmenton May 4, 2024 at 7:50 am
A personalized mRNA vaccine to treat melanoma has now reached late-stage trials in the UK. This is just the latest step in improving the cure rate of cancer.
- Advancing genomic medicine: National Cancer Center Japan's role in personalized cancer treatmenton May 2, 2024 at 5:00 pm
In a significant stride towards personalized cancer care, the National Cancer Center Japan (NCCJ) has marked a decade of progress in cancer genomic medicine (CGM).
- MIT Technology Reviewon May 2, 2024 at 5:00 pm
Personalized cancer vaccines like the ones ... cancer doesn’t automatically mean success against all. Plenty of cancer therapies have shown enormous promise initially, only to fail when they ...
- MRNA vaccine effective in treating glioblastoma brain cancer in small trialon May 2, 2024 at 9:24 am
An experimental cancer vaccine can quickly reprogram a person's immune system to attack glioblastoma, the most aggressive and lethal form of brain cancer, a small, preliminary study has found.
- Novel mRNA Vaccine Shows Promise Against Deadly Brain Canceron May 1, 2024 at 1:24 pm
Researchers introduced a new mRNA cancer vaccine that rapidly activates the immune system against glioblastoma, the deadliest form of brain tumor.
- British Man Tests First Personalized Melanoma Vaccineon April 30, 2024 at 4:07 am
The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486426/) ...
The Latest Google Headlines on:
Personalized cancer therapies
[google_news title=”” keyword=”personalized cancer therapies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Personalized medicine
- Global Companion Diagnostics Research Report 2024-2029: Innovations in Companion Diagnostics Boost Drug Development and Personalized Medicineon May 9, 2024 at 12:43 am
Factors such as the increasing importance of companion diagnostics in drug development, rising cancer incidence, and the growing adoption of targeted therapies are driving market growth.
- Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Regionon May 7, 2024 at 8:56 am
Biocartis (Mechelen, Belgium) announced an expansion of its collaboration with Merck Serono Middle East and Merck Saudi Ltd., both affiliates of Merck KGaA (“Merck”). The collaboration aims to improve ...
- Study finds personalized antibiotics, prebiotics, and probiotics combo may help treat IBSon May 6, 2024 at 8:00 pm
A study presented at the European Society of Clinical Microbiology and Infectious Diseases conference revealed that over a third of patients treated with a precision approach to post-infectious ...
- OM1 Launches Three New Products Powered by Patented AI Platform to Expedite Delivery of Personalized Medicineon May 6, 2024 at 6:00 am
OM1 Orion, OM1 Lyra, and OM1 Polaris powered by PhenOMTM – an artificial intelligence-powered digital phenotyping platform for personalized medicine and clinical research. OM1 is the leader in ...
- Can a personalized antibiotics, prebiotics, and probiotics combo help treat IBS?on May 4, 2024 at 11:00 pm
A pilot study suggests that a personalized combination of antibiotics, prebiotics, and probiotics may help treat the symptoms of post-infectious irritable bowel syndrome (IBS).
- Molecular Profiling and Companion Diagnostics: Where is Personalized Medicine in Cancer Heading?on May 4, 2024 at 5:00 pm
The goal of personalized medicine is to use the right drug at the right dose – with minimal or no toxicity – for the right patient at the right time. Recent advances in understanding cell ...
- How AI Revolutionizes Lab Tests: Faster, Smarter, More Personalizedon April 30, 2024 at 12:36 pm
AI revolutionizes lab diagnostics with faster, more precise, and personalized testing, significantly improving patient care and ...
- 'Despite promise, personalized medicine for head and neck cancers facing hurdles'on April 26, 2024 at 3:45 am
Improved efficacy: By identifying specific mutations driving tumour growth, personalized medicine allows for targeted therapies that have a higher success rate compared to ‘one-size-fits-all’ ...
- Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and moreon April 12, 2024 at 5:00 pm
This essay supports my assertion that the fiscal issues that might hinder the usefulness of personalized medicine need to be dealt with at the same time as we continue our progress towards large ...
- Personalized medicine: We’re not there yeton April 4, 2024 at 5:00 pm
He predicted that in 10 years personalized medicine would allow physicians to employ “predictive genetic tests … so that each of us can learn of our individual risks for future illness and ...
The Latest Google Headlines on:
Personalized medicine
[google_news title=”” keyword=”personalized medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]